Role of CMR-FT in Assessment of HCM and Athlete's Heart.

The Role of Cardiac MRI Feature Tracking in Assessment of Hypertrophic Cardiomyopathy and Athlete's Heart.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06859827

Enrollment

Registered

2025-03-05

Start date

2024-12-15

Completion date

2025-12-15

Last updated

2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athlete Heart, Hypertrophic Cardiomyopathies

Keywords

Cardiac MRI feature tracking, Hypertrophic cardiomyopathy, Athlete's heart

Brief summary

Using cardiac MRI feature tracking to asses myocardial motion differences in athlete's heart and discovered hypertrophic cardiomyopathy patients to increase diagnostic accuracy of hypertrophic cardiomyopathy.

Detailed description

Cardiac MRI is the gold standard for assessing cardiac function without significant limitations of anatomical restrictions. CMR-FT helps in assessment of myocardial deformation on routinely obtained by steady state free precision (SSFP) cine images. CMR-FT is used in cardiac research and became common in clinical practice. It has been used in assessment of wide spectrum of cardiac diseases and provides for comprehensive and reliable assessments of heart function.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients suspected to be hypertrophic cardiomyopathy by echocardiography.. * Athletes and heavy workers,, healthy volunteers also included.

Exclusion criteria

* Patients with absolute or relative contraindications to magnetic resonance imaging (e.g intra-ocular metallic foreign body, claustrophobia, etc) or contra-indication to MRI contrast medium. * Clinical morbidities with absolute contraindication to anesthesia during the examination in un-cooperative patients where sedation is required.

Design outcomes

Primary

Measure	Time frame	Description
Use of cardiac MRI feature tracking in detection of myocardial deformation abnormalities and diagnostic confirmation and detection of hypertrophic cardiomyopathy.	6months to 12 months	The main goal of the study is evaluating the role of Cardiac magnetic resonance feature tracking analysis in detection of myocardial deformation abnormalities in cases of hypertrophic cardio myopathy and compare it with physiological hypertrophy in athletes. Identification of strain patterns in hypertrophic cardiomyopathy.

Countries

Egypt

Outcome results